ArticleTargeted oncology2018

Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma.

Takashi Ikeda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.